Biotechnology stocks have corrected nicely in recent weeks, but that doesn’t mean they can’t slip further. Gilead Sciences is breaching an important line here today and barring any sudden bullish reversal, looks like it can further accelerate to the downside.
Serge Berger
TheSteadyTrader.com
